Work

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9532-1

Authors: George P. Kim, Michelle R. Mahoney, Daniel Szydlo, Tony S. K. Mok, Robert Marshke, Kyle Holen, Joel Picus, Michael Boyer, Henry C. Pitot, Joseph Rubin, Philip A. Philip, Anna Nowak, John J. Wright, Charles Erlichman

Institutions: Mayo Clinic in Florida, Mayo Clinic, National University Hospital, Mayo Clinic in Arizona, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Washington University in St. Louis, Royal Prince Alfred Hospital, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Sir Charles Gairdner Hospital, National Institutes of Health, National Cancer Institute

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G494398503, Early Therapeutics Development with Phase II Emphasis, G599695825

OpenAlex ID: W2124426490

FWCI: 2.095

Cites: 35

Cited by: 71

Related to: 10